drugset / Trial / NCT01219673
Symptom Burden in Head and Neck Cancer
Phase 1/2
Terminated
1 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this clinical research study is to compare armodafinil, bupropion, and minocycline when given alone or in combination. Researchers want to learn about the safety and level of effectiveness of these drugs in controlling symptoms, such as the side effects of chemoradiation, when given to patients with head and neck cancer.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Armodafinil | Small molecule | 150 mg | Oral |
| Subject | Bupropion | Small molecule | 100 mg | Oral |
| Subject | Minocycline | Small molecule | 100 mg | — |